About
Astratus develops a rapid antimicrobial susceptibility testing platform that uses a microcapillary dip-and-test assay cartridge and instrument reader to deliver digitised AST results in under 6 hours for human, veterinary, and research laboratories, aiming to replace slower, manual methods.
Explore Astratus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.